LANGERHANS CELL HISTIOCYTOSIS
Clinical trials for LANGERHANS CELL HISTIOCYTOSIS explained in plain language.
Never miss a new study
Get alerted when new LANGERHANS CELL HISTIOCYTOSIS trials appear
Sign up with your email to follow new studies for LANGERHANS CELL HISTIOCYTOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with rare cancer: major trial tests simpler treatment
Disease control Recruiting nowThis study is testing if a single chemotherapy drug (cytarabine) works as well or better than the current standard two-drug combination (vinblastine/prednisone) for treating Langerhans cell histiocytosis (LCH), a rare cancer. It will enroll 124 children and young adults up to age…
Matched conditions: LANGERHANS CELL HISTIOCYTOSIS
Phase: PHASE3 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
New hope for rare blood disorder: testing a gentler chemo combo
Disease control Recruiting nowThis study is testing whether a combination of two existing drugs—a low-dose chemotherapy (cytarabine) and thalidomide—can effectively control Langerhans cell histiocytosis (LCH) in adults who haven't had treatment before. It aims to see if this regimen can keep the disease in ch…
Matched conditions: LANGERHANS CELL HISTIOCYTOSIS
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC